<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: Non-<z:e sem="disease" ids="C0242363" disease_type="Neoplastic Process" abbrv="">islet-cell tumor</z:e> <z:hpo ids='HP_0001943'>hypoglycemia</z:hpo> (NICTH) is a rare cause of <z:hpo ids='HP_0001943'>hypoglycemia</z:hpo> associated with <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> of mesenchymal, epithelial, or hematopoietic origin </plain></SENT>
<SENT sid="1" pm="."><plain><z:hpo ids='HP_0003128'>Lactic acidosis</z:hpo> is likewise an uncommon complication of <z:e sem="disease" ids="C0848852,C0376545" disease_type="Neoplastic Process" abbrv="">hematological malignancy</z:e> associated mainly with <z:hpo ids='HP_0001909'>leukemia</z:hpo> and <z:hpo ids='HP_0002665'>lymphoma</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>Most cases of NICTH and <z:hpo ids='HP_0003128'>lactic acidosis</z:hpo> have been described in the adult population </plain></SENT>
<SENT sid="3" pm="."><plain>We report a child with congenital HIV and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AIDS</z:e> who developed Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo>, <z:hpo ids='HP_0003128'>lactic acidosis</z:hpo> and NICTH </plain></SENT>
<SENT sid="4" pm="."><plain>PATIENT: An 11 year-old boy with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AIDS</z:e>, <z:hpo ids='HP_0100021'>cerebral palsy</z:hpo> and <z:hpo ids='HP_0001250'>seizure</z:hpo> disorder presented with intractable <z:hpo ids='HP_0001943'>hypoglycemia</z:hpo> 12 days after diagnosis of Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> </plain></SENT>
<SENT sid="5" pm="."><plain>He had persistent <z:hpo ids='HP_0001943'>hypoglycemia</z:hpo> (serum <z:chebi fb="105" ids="17234">glucose</z:chebi> 20-40 mg/dl; 1.1-2.2 mmo/l) despite <z:chebi fb="105" ids="17234">glucose</z:chebi> infusion rate of 6 mg/kg/minute and trial of <z:chebi fb="0" ids="4495">diazoxide</z:chebi> treatment </plain></SENT>
<SENT sid="6" pm="."><plain>Critical sample obtained at time of <z:hpo ids='HP_0001943'>hypoglycemia</z:hpo> showed insulin at 1.78 microU/ml (<z:mpath ids='MPATH_458'>normal</z:mpath> &lt;5 microU/ml), pro-insulin 5.6 pmol/l (&lt;18.8 pmol/l), IGF-I &lt;25 ng/ml (80-723 ng/ml), IGF-II 422 ng/ml (610-1,217 ng/ml), <z:chebi fb="4" ids="24996">lactate</z:chebi> 15.6 mmol/l (<z:mpath ids='MPATH_458'>normal</z:mpath>: 0.5-2.2 mmol/l), <z:chebi fb="1" ids="17650">cortisol</z:chebi> 21 microg/dl (580 nmol/l; <z:mpath ids='MPATH_458'>normal</z:mpath> &gt;10 microg/dl; 276 nmol/l), and negative insulin antibodies </plain></SENT>
<SENT sid="7" pm="."><plain>He remained alert and <z:hpo ids='HP_0001250'>seizure</z:hpo> free despite profound <z:hpo ids='HP_0001943'>hypoglycemia</z:hpo> </plain></SENT>
<SENT sid="8" pm="."><plain>A 1 mg glucagon stimulation test showed a rise in serum <z:chebi fb="105" ids="17234">glucose</z:chebi> of 29 mg/dl (&gt;1.6 mmol/l) </plain></SENT>
<SENT sid="9" pm="."><plain>Continuous glucagon infusion at 0.15-0.3 mg/h maintained euglycemia until the time of his demise (1 month after admission) due to complications of his underlying illness </plain></SENT>
<SENT sid="10" pm="."><plain>CONCLUSION: We present a case of <z:hpo ids='HP_0003128'>lactic acidosis</z:hpo> and NICTH in an 11 year-old boy with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AIDS</z:e> and Burkitts's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> </plain></SENT>
<SENT sid="11" pm="."><plain>We review the mechanism of <z:hpo ids='HP_0003128'>hyperlacticacidemia</z:hpo> in supporting cerebral function during profound <z:hpo ids='HP_0001943'>hypoglycemia</z:hpo> </plain></SENT>
<SENT sid="12" pm="."><plain>NICTH and <z:hpo ids='HP_0003128'>lactic acidosis</z:hpo> in association with <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">malignancy</z:e> carries a poor prognosis </plain></SENT>
<SENT sid="13" pm="."><plain>In this patient, continuous glucagon infusion was a successful alternative to <z:chebi fb="0" ids="50858">corticosteroid</z:chebi> treatment in maintaining euglycemia </plain></SENT>
</text></document>